Camp4 Therapeutics (CAMP) Share-based Compensation (2023 - 2026)

Camp4 Therapeutics' Share-based Compensation history spans 3 years, with the latest figure at $1.2 million for Q4 2025.

  • On a quarterly basis, Share-based Compensation rose 44.42% to $1.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.0 million, a 0.82% decrease, with the full-year FY2025 number at $4.0 million, down 0.84% from a year prior.
  • Share-based Compensation hit $1.2 million in Q4 2025 for Camp4 Therapeutics, up from $984000.0 in the prior quarter.
  • Over the last five years, Share-based Compensation for CAMP hit a ceiling of $1.6 million in Q3 2024 and a floor of $636000.0 in Q4 2023.
  • Historically, Share-based Compensation has averaged $938700.0 across 3 years, with a median of $858500.0 in 2024.
  • Biggest five-year swings in Share-based Compensation: soared 120.5% in 2024 and later plummeted 38.19% in 2025.
  • Tracing CAMP's Share-based Compensation over 3 years: stood at $636000.0 in 2023, then increased by 25.31% to $797000.0 in 2024, then skyrocketed by 44.42% to $1.2 million in 2025.
  • Business Quant data shows Share-based Compensation for CAMP at $1.2 million in Q4 2025, $984000.0 in Q3 2025, and $1.0 million in Q2 2025.